A detailed history of Covestor LTD transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Covestor LTD holds 7 shares of VRDN stock, worth $169. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 8 12.5%
Holding current value
$169
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$12.16 - $23.33 $12 - $23
-1 Reduced 12.5%
7 $0
Q2 2024

Aug 09, 2024

BUY
$11.6 - $17.26 $46 - $69
4 Added 100.0%
8 $0
Q1 2024

May 10, 2024

SELL
$17.09 - $23.82 $17 - $23
-1 Reduced 20.0%
4 $0
Q3 2023

Nov 13, 2023

BUY
$15.16 - $24.7 $30 - $49
2 Added 66.67%
5 $0
Q1 2023

May 15, 2023

BUY
$25.04 - $37.6 $75 - $112
3 New
3 $0

Others Institutions Holding VRDN

About Viridian Therapeutics, Inc.\DE


  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $968M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.